AI-generated summary
The authors report a single-center randomized controlled trial comparing bright light therapy with standard light in people with dementia. They found limited evidence of reduced agitation in the active treatment group, with improved sleep and a suggestion of greater benefit in winter. The authors conclude that bright light therapy is a potential alternative to drug treatment for agitation, though the trial was not retrospectively registered.
- Who or what was studied
- People with dementia who are agitated
- Limits stated in the abstract
- The abstract reports only limited evidence for reduced agitation, the trial was not registered, and no participant total is stated.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Dementia, Bright light therapy, Randomized controlled trial. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.